NCT00733226View on ClinicalTrials.gov

Effect of OM-85 BV on Wheezing Related Morbidity in Children With Recurrent Wheezing

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

October 31, 2008

Conditions
Asthma
Interventions
DRUG

OM-85 BV (Broncho-Vaxom)

3.5 mg capsule, 1 capsule per day for first 10 day of the month, for 3 months

DRUG

OM-85 BV (placebo)

3.5 mg oral placebo capsule, 1 placebo capsule per day for first 10 days of the months for 3 months

Trial Locations (2)

06380

Kecioren Education and Training Hospital, Ankara

Keçiören Education and Training Hospital, Ankara

All Listed Sponsors
lead

Kecioren Education and Training Hospital

OTHER

NCT00733226 - Effect of OM-85 BV on Wheezing Related Morbidity in Children With Recurrent Wheezing | Biotech Hunter | Biotech Hunter